Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study

(2018) Ton Fang et al.   LANCET NEUROLOGY

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

(2018) Henk-Jan Westeneng et al.   LANCET NEUROLOGY

Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort

(2018) Nimish J. Thakore et al.   MUSCLE & NERVE

Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model

(2017) Leonhard A. Bakker et al.   JOURNAL OF NEUROLOGY

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

(2017) Koji Abe et al.   LANCET NEUROLOGY

Comparison of the King’s and MiToS staging systems for ALS

(2017) Ton Fang et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Multi-State Models for Panel Data: ThemsmPackage forR

(2015) Christopher H. Jackson   Journal of Statistical Software

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials

(2014) Rubika Balendra et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The PRO-ACT database: Design, initial analyses, and predictive features

(2014) N. Atassi et al.   NEUROLOGY

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis

(2014) Ashley R. Jones et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

(2014) Koji Abe et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients

(2014) Hazuki Watanabe et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale

(2014) Rubika Balendra et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis

(2013) Adriano Chiò et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis

(2013) Franco Franchignoni et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A proposed staging system for amyotrophic lateral sclerosis

(2012) J. C. Roche et al.   BRAIN

The relative efficiency of time-to-threshold and rate of change in longitudinal data

(2011) M.C. Donohue et al.   Contemporary Clinical Trials

Semi-Markov Models with Phase-Type Sojourn Distributions

(2009) Andrew C. Titman et al.   BIOMETRICS

Bias in Markov models of disease

(2009) Daniel M. Faissol et al.   MATHEMATICAL BIOSCIENCES

ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration

(2009) J. M. Ravits et al.   NEUROLOGY